Evronal
Evronal Brand names, Evronal Analogs
- (+/-)-Secobarbital
- Barbosec
- Bipanal
- Bipinal sodium
- DEA No. 2315
- DEA No. 2316
- Evronal
- Evronal Sodium
- Evrronal
- Hypotrol
- Hyptran
- Imesonal
- Immenoctal
- Immenox
- Meballymal
- Meballymal sodium
- Meballymalum
- Novosecobarb
- Pramil
- Quinalbarbital
- Quinalbarbitone
- Quinalbarbitone sodium
- Quinalspan
- Sebar
- Seco 8
- Secobarbital (USP)
- Secobarbital Sodium
- Secobarbital [USAN:INN]
- Secobarbital suppository dosage form
- Secobarbitale [DCIT]
- Secobarbitalum [INN-Latin]
- Secobarbitone
- Seconal
- Seconal (TN)
- Seconal Sodium
- Sedutain
- Seotal
- Sodium Secobarbital
- Sodium Seconal
- Sodium quinalbarbitone
- Somosal
- Synate
- Trisomnin
Evronal Brand Names Mixture
- No information avaliable
Evronal Chemical_Formula
C12H18N2O3
Evronal RX_link
No information avaliable
Evronal fda sheet
Evronal msds (material safety sheet)
Evronal Synthesis Reference
No information avaliable
Evronal Molecular Weight
238.283 g/mol
Evronal Melting Point
100 oC
Evronal H2O Solubility
550 mg/L
Evronal State
Solid
Evronal LogP
1.879
Evronal Dosage Forms
Capsule
Evronal Indication
For the Short-term treatment of intractable insomnia for patients habituated to barbiturates
Evronal Pharmacology
Secobarbital, a barbiturate, is used for the induction of anesthesia prior to the use of other general anesthetic agents and for induction of anesthesia for short surgical, diagnostic, or therapeutic procedures associated with minimal painful stimuli. Little analgesia is conferred by barbiturates; their use in the presence of pain may result in excitation.
Evronal Absorption
No information avaliable
Evronal side effects and Toxicity
No information avaliable
Evronal Patient Information
No information avaliable
Evronal Organisms Affected
Humans and other mammals
